Moreover, in contrast to the near-complete tumor regression achieved in the CPA + control IgG group, an extended period of tumor growth stasis followed by robust tumor regrowth was evident in mice receiving CPA + anti-CD8α antibody (Fig. 7A). The gene discussed is CD8A; the disease is neoplasm.